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Abstract
Background: In recent decades, considerable progress in diagnosis and treatment of patients with intoxication-type
inborn errors of metabolism (IT-IEM) such as urea cycle disorders (UCD), organic acidurias (OA), maple syrup urine
disease (MSUD), or tyrosinemia type 1 (TYR 1) has resulted in a growing group of long-term survivors. However, IT-IEM
still require intense patient and caregiver effort in terms of strict dietetic and pharmacological treatment, and the threat
of metabolic crises is always present. Furthermore, crises can affect the central nervous system (CNS), leading to
cognitive, behavioural and psychiatric sequelae. Consequently, the well-being of the patients warrants consideration
from both a medical and a psychosocial viewpoint by assessing health-related quality of life (HrQoL), psychological
adjustment, and adaptive functioning. To date, an overview of findings on these topics for IT-IEM is lacking. We
therefore aimed to systematically review the research on HrQoL, psychological adjustment, and adaptive functioning
in patients with IT-IEM.
Methods: Relevant databases were searched with predefined keywords. Study selection was conducted in two steps
based on predefined criteria. Two independent reviewers completed the selection and data extraction.
Results: Eleven articles met the inclusion criteria. Studies were of varying methodological quality and used different
assessment measures. Findings on HrQoL were inconsistent, with some showing lower and others showing higher or
equal HrQoL for IT-IEM patients compared to norms. Findings on psychological adjustment and adaptive functioning
were more consistent, showing mostly either no difference or worse adjustment of IT-IEM patients compared to norms.
Single medical risk factors for HrQoL, psychological adjustment, or adaptive functioning have been addressed, while
psychosocial risk factors have not been addressed.
Conclusion: Data on HrQoL, psychological adjustment, and adaptive functioning for IT-IEM are sparse. Studies are
inconsistent in their methodological approaches, assessment instruments and norm populations. A disease-specific
standard assessment procedure for HrQoL is not available. Psychosocial risk factors for HrQoL, psychological adjustment,
or adaptive functioning have not been investigated. Considering psychosocial variables and their corresponding risk
factors for IT-IEM would allow evaluation of outcomes and treatments as well as the planning of effective social and
psychological interventions to enhance the patients’ HrQoL.
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Introduction
Intoxication-type inborn errors of metabolism (IT-IEM) are
a group of inborn errors of metabolism (IEM) which share
distinct clinical features. The group encompasses urea cycle
disorders (UCD), organic acidurias (OA), tyrosinemia type
1 (TYR 1), and maple syrup urine disease (MSUD). The es-
timated incidence is between 1:8,000 to 1:44,000 for UCD
[1,2], about 1:21,000 for OA [2], about 1:100,000 for TYR 1
[3] and about 1:185,000 for MSUD [4].
Patients with IT-IEM share two main clinical features:
they have to follow a strict diet, and they live with the per-
manent risk of metabolic crises. These can be triggered by
alterations in diet, common infections, or stress but may
also occur without predictive circumstances. In cases of
metabolic crises, patients immediately require intensified
home care or hospitalisation. Despite such efforts, crises
remain life-threatening and may cause organ and central
nervous system (CNS) damage [5]. To ensure correct diet
and an appropriate reaction in risk situations, patients and
their families are obliged to develop extensive knowledge
about the disease.
Intense biomedical research in the field of IT-IEM has
resulted in substantial advances in treatment and a grow-
ing group of surviving patients [6]. These individuals have
to cope with stressors such as strict diet, medication,
crises management, and uncertainties about the future
course of their disease and its consequences. Furthermore
patients may have behavioural, cognitive, or psychiatric
problems due to the CNS alterations caused by the disease
[5], which again impair their psychological functioning
[7,8]. As a result, even though treatments have improved,
IT-IEM affect the daily life and well-being of patients and
their caregivers considerably [9]. Therefore, complemen-
tary research from a psychosocial perspective is especially
needed [9,10].
Health-related quality of life (HrQoL), psychological
adjustment, and adaptive functioning are well-established
constructs to describe psychosocial consequences of
chronic diseases. HrQoL has been defined as “a patient’s
perception of the impact of disease and treatment on
functioning in a variety of dimensions, including physical,
psychological and social domains” [11], p.126. Adjustment
describes the healthy rebalancing of patients to a new con-
dition [12]. We use the more specific term psychological
adjustment to refer specifically to emotional, behavioural
or social adjustment to a disease. Finally, adaptive func-
tioning is a related term describing “the performance of
daily activities required for personal and social sufficiency”
([13], p.6), consisting of the three domains conceptual,
practical and social functioning [14]. To date, no consen-
sus has arisen about how HrQoL, psychological adjust-
ment, and adaptive functioning are affected in IT-IEM
patients and what factors can influence the well-being of
the patients. An overview of findings is lacking. For this
reason, we decided to systematically review the current re-
search on HrQoL, psychological adjustment, and adaptive
functioning in IT-IEM patients. Our purpose was to an-
swer two research questions:
(1)What is the current state of knowledge about
self- and proxy-reported HrQoL, psychological
adjustment, and adaptive functioning in IT-IEM
patients?
(2)What are the medical and psychosocial risk factors
for HrQoL, psychological adjustment, and adaptive
functioning in IT-IEM patients?
Methods
Data sources and search strategies
To identify eligible studies for our review, we searched
relevant databases with pre-defined search terms. The
search was conducted using the following electronic bib-
liographic databases up to 30 April 2013: Pubmed,
Embase, Cinahl, PsycINFO, Psyndex and the Cochrane
Database of Clinical Trials and Systematic Reviews.
NDLTD (Networked Digital Library of Theses and Disser-
tations) and dissonline.de were searched to find eligible
dissertations. We applied two groups of search terms.
Firstly, we employed various disease names referring to
IEM and IT-IEM. Secondly, we referred to HrQoL,
psychological adjustment, and adaptive functioning by
employing these terms: quality of life, life satisfaction, well
being, well-being, wellbeing, adjustment, adaption, adapta-
tion, adaptive, psycholog*, psychosocial, psychiatr*, social,
emotional, mental health, mental disorder, mental disease,
behavior*, behaviour*. To augment the specificity of the
search, the IEM/IT-IEM group and the HrQoL/psycho-
logical adjustment/adaptive functioning group were con-
nected to each other by the Boolean operator “AND”,
whereas terms within the groups were connected by the
Boolean operator “OR”. We also took advantage of other
options to refine the search when the databases offered
them; accordingly, search terms concerning IEM, HrQoL,
psychological adjustment, and adaptive functioning were
limited to titles and abstracts, and words with multiple
possible endings or spellings were completed by wildcards.
An additional search for studies was conducted in two
ways. First, to minimise publication bias, experts in the
field were contacted via e-mail and asked if they were
aware of any relevant articles or unpublished data. In
addition, the references of relevant articles were screened.
Study selection
To find eligible studies, we rated all the articles and
dissertations found in our systematic search according
to pre-defined inclusion and exclusion criteria. Studies
were included if the number of participants was N >1
and if the sample contained at least 50% IT-IEM patients
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or if the results of IT-IEM patients were reported separ-
ately. Outcomes had to include a self-, proxy-, or exam-
iner’s report of patients’ HrQoL, patients’ psychological
adjustment (psychological, social, behavioural, or emotional
adjustment), or adaptive functioning. The assessment of
these outcomes had to be completed in a standardised way
and reported quantitatively. Reporting of methods and re-
sults had to be sufficient for replicability. Finally, reports
were accepted if they were written in English, German,
French, or Spanish. Articles not fulfilling these criteria were
excluded. The selection process was conducted in two
major steps. First, one reviewer (N.A.Z.) examined all titles
and abstracts. Second, studies that could not be excluded
in the first examination were rated in their full-text ver-
sion by two reviewers (N.A.Z. and M.H.) independently.
Inter-rater reliability was substantial [10], with Cohen’s
kappa = 0.79. Any disagreements were arbitrated through
discussion. The remaining articles were included for data
extraction.
Data extraction and analysis
Two reviewers (N.A.Z. and M.A.L.) extracted the data of
the articles independently. Inter-rater reliability was
almost perfect [15], with Cohen’s kappa =0.98. Disagree-
ments were resolved through discussion. The great vari-
ation between studies regarding design, such as measures
and reporting of results, did not permit statistical pooling
of data from the individual studies, so meta-analytic
calculations were not possible. Instead, effect sizes were
calculated whenever possible to attain some comparability
between the results. Standardised mean differences, in-
cluding 95% confidence intervals (CI), were calculated for
continuous outcomes using Cohen’s d effect sizes, cor-
rected for small sample sizes [16]. An effect size was con-
sidered to be significant if its 95% CI did not include 0,
thus considering a significance level of p < .05. According
to Cohen’s categories, an effect size is small if d = 0.2 -
0.5, medium if d = 0.5 - 0.8 and large if d >0.8 [17]. Calcu-
lations were conducted such that a positive Cohen’s d
stands for a higher scoring of the IT-IEM group than of
norms. Higher scorings are favourable for all scales, except
for two cases: the Child Behaviour Checklist (CBCL) and
the Behaviour Assessment System for Children (BASC) (all
subscales but adaptive skills) report problem behaviour.
Consequently, higher scores signify more problems and are
unfavourable outcomes. For dichotomous outcomes, we
used Chi-square tests, indicating the strength of the associ-
ation by Cramer’s V, with p < .05 considered significant.
IBM SPSS Statistics for Windows, Version 20.0 was used
for all calculations.
Results
The initial search of databases revealed 1669 articles and
dissertations. After the first selection, 20 articles remained.
During the second selection process, we had to exclude
another nine articles; three were single-case reports, one
had the same sample as another article included, and
seven articles lacked standardised assessments of the
patients’ HrQoL, psychological adjustment, or adaptive
functioning. One of these articles was a qualitative study
[18]. One additional, recently published article [19] was
found by contacting experts in the field, and another was
traced [20] by screening the references of relevant studies.
The search and selection process is depicted in Figure 1.
Finally, 11 articles remained for further analyses.
Study description
The main characteristics and results of the articles in-
cluded in our review are summarised in Table 1. Further
information about the assessment instrument used in
the studies can be found in Table 2. Detailed analyses of
outcome parameters are shown in Tables 3 and 4. All 11
articles were published between 2006 and 2013, seven of
them in 2012 or 2013. Four articles have their origins in
the United States, two in Germany, and one each in
Australia, Belgium, Italy, Poland, and Turkey. All articles
are written in English. All of the four disease groups we
searched for (UCD, OA, MSUD, TYR 1) are represented
in the final selection of studies. Patients diagnosed with
MSUD (n = 124) represent the largest group, followed
by OA (n = 107), UCD (n = 100) and TYR 1 (n = 8).
Seven studies reported outcomes for only one of these
disease groups, four studies included patients of mul-
tiple groups. From six articles, only subgroup data
were extracted. In four studies, we selected IT-IEM
patients from the original samples, which integrated
patients with IT-IEM and patients with other diseases
[19,21-23]. One study reported on IT-IEM patients
before and after transplantation. Only the subgroup be-
fore transplantation was selected for further analysis
[24]. In another study, outcome regarding adaptive
functioning was only available for a subgroup [20]. The
final sizes considered ranged from N = 4 to N = 92
patients.
Many of the studies had methodological limitations.
One main weakness is the lack of appropriate participant
selection (i.e. use of convenience samples) in order to
avoid selection or non-response bias [22-29]. Two studies
involved a non-validated measuring tool [19,23]. Further-
more, only two studies considered multiple informants in
terms of self- and proxy-ratings [21,28].
Findings on HrQoL
Self-report
As shown in Table 3, results for self-reported HrQoL are
inconsistent across studies. In one study, the authors
reported significantly lower HrQoL for IT-IEM patients in
most domains compared to population norms [28]. The
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results for IT-IEM patients were closer to the results of a
cancer population than to a healthy one. Two other stud-
ies showed results with more variance throughout the dif-
ferent HrQoL domains. One study reported clearly lower
scores for IT-IEM patients than for population norms in
the psychological and the friends domains, but higher
scores for the school domain [26]. The results for other
domains did not differ from norms. Half of the patients in
the sample of this study did not categorise themselves as
“ill”. In contrast, another group of researches reported sig-
nificantly better scores in the physical domain for IT-IEM
patients compared to population norms [22], but lower
scores in the environmental domain (including e.g. finan-
cial resources, health care, physical environment). The
same study found HrQoL of IT-IEM patients to be similar
to that of patients with phenylketonuria, who also have to
follow a strict diet but who do not face the risk of sudden
metabolic crises. Furthermore, IT-IEM patients had higher
HrQoL in most domains compared to Morbus Fabry
patients, who often have to deal with pain symptoms, and
patients with metabolic diseases under pharmacological
(as opposed to dietary) treatment [22].
Proxy-report
Proxy-ratings of HrQoL were all reported by parents. All
results for IT-IEM patients were either not different from
norms or unfavourable for IT-IEM patients (Table 3). One
study showed significantly lower parent-rated HrQoL for
IT-IEM patients across all domains compared to popula-
tion norms [28]. In line with the results for self-reported
HrQoL in the same study, the results were closer to can-
cer population norms than to healthy norms. Psychosocial
and social domains were lower in IT-IEM patients than in
the cancer population. In another article, the parent-rated
HrQoL of IT-IEM patients was compared with the
parent-rated HrQoL of patients with other metabolic dis-
eases (aminoacid metabolic disorders and carbohydrate
metabolic disorders) [23]. IT-IEM patients scored lower in
the domains of school functioning, health perception (com-
pared with both diseases) and physical functioning (only
compared with aminoacid metabolic disorders).
Self- vs. proxy-report
One study [28] compared self- and parent proxy-ratings.
The authors reported significantly better scores in self-
reported HrQoL for the domains of physical, emotional
and social HrQoL, but no difference for school functioning.
Risk factors
No risk factors regarding HrQoL were investigated in
the studies.
Findings on psychological adjustment and adaptive
functioning
Self-report
Results for self-reported psychological adjustment and
adaptive functioning are shown in Tables 3 and 4. De-
pression and anxiety (both current and lifetime) were
reported to be more prevalent in a group of IT-IEM
patients than in a healthy group [24]. However, the study
revealed no differences between IT-IEM patients and
population norms regarding anxiety and depression
symptom severity. Another research group found adap-
tive functioning for IT-IEM patients to be significantly
lower than in a norm population [20].
Proxy-report
All studies used parent proxy-reports and one additionally
used teacher proxy-reports (Tables 3 and 4). Proxy-report
findings on different aspects of psychological adjustment
and adaptive functioning mostly showed either no
difference or worse adjustment and more problems for
IT-IEM patients than norms [21,26-29]. Fewer problems
Initial search: 
1669 articles and theses
After second selection (full text):
9 articles
Additional search:
2 articles
Asking experts in the field (1), screening of 
references (1)
After first selection (titles and abstract):
20 articles
Final inclusion:
11 articles
Excluded:
11 articles
Reasons: no standardized assessment of the 
patients’ HrQoL or psychological adjustment (7, of 
which 1 qualitative study); single-case report (3); 
same sample as other included article (1)
Excluded:
1649 articles and theses
According to inclusion and exclusion criteria
Figure 1 Flowchart of study selection.
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Table 1 Main characteristics of the reviewed studies
Author,
year
(origin)
Metabolic disease N* Reviewed sample vs.originally reported sample
Mean age in
years (range)
Group of
comparison
Assessment instrument
(report)
Selected results** (IT-IEM
related to group of comparison)
Beauchamp
et al., 2009
(Australia)
[25]
GA I 4 Same 5.8 (5 to 7) Population
norms
• CBCL (proxy-mother) • Psychological adjustment (CBCL): No
sign. group difference, except for CBCL
total scale, where IT-IEM patients show less
behavioural problems than the norm
population (doubt about reliability of
this result)
• ABAS (proxy-mother) • Adaptive functioning (ABAS): No sign.
group difference
Cazzorla
et al., 2012
(Italy) [22]
OTCD, HHH Syndrome,
ASA, GA I, MMA, MSUD
15 Reviewed sample: only
IT-IEM
Orig. sample: IT-IEM
mixed with other diseases
(N = 82)
25.6 (17 to 44) Population
norms, other
IEM-groups: PKU,
Morbus Fabry,
pharmacological
treatment
• WHOQOL-100 (self ) • QoL (WHOQOL-100): Compared to
population norms: sign. higher QoL for
physical domain, lower for environmental
domain, no sign. group difference for all
other domains
• QoL (WHOQOL-100): Compared to
other IEM: no sign. group difference
compared to PKU for all domains, sign.
higher compared to Morbus Fabry and
pharmacologically treated patients in most
domains (no sign. group difference for
social and environmental domains)
Eminoglu
et al., 2013
(Turkey) [23]
MA, PA, MSUD (group includes
n = 3 patients with a disease
not being an IT-IEM)
14 Reviewed sample: separately
reported subgroup, mainly
IT-IEM, 3 other IEM
Orig. sample: IT-IEM mixed
with other IEM (N = 68)
4.7 (n.a., SD = 4.3) Population
norms, other
IEM-groups:
CMD and AMD
• Questionnaire constructed by
authors: QoL Scale for Metabolic
Diseases (proxy-parent)
• HrQoL (QoL Scale for Metabolic
Diseases): Sign. lower compared to CMD
and AMD for school status and health
perception domains, sign. lower in
physical function domain compared to
AMD, similar for other domains
• Kiddy-, Kid- Kiddo-KINDL
(proxy-parent, self if > = 4 years)
• HrQoL (KINDL): No sign. group
difference compared to CMD and AMD for
emotional wellbeing domain
Gramer
et al., 2013
(Germany)
[19]
ASLD, GA I, IVA, PA, MSUD 34 Reviewed sample: only IT-IEM
Orig. sample: IT-IEM mixed
with other IEM (N = 187)
4 (1.2 to 9.7) None Questionnaire constructed
by authors, assessing:
• Perceived burden for the child
(proxy-parent)
• Psychological adjustment (Perceived
burden for the child): Rated as low for
the majority (50%)
• Social behavior (proxy-parent) • Psychological adjustment (Social
behaviour): Rated average for the
majority (82%)
Grünert
et al., 2013
(Germany)
[26]
PA 48 Same 5 (5 days to 19) Population
norms
• Kid-KINDL (self ): n = 18 • HrQoL (KINDL): Sign. lower HrQoL for
psychological and friends domain, sign.
higher for school domain, no group
difference for other domains
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Table 1 Main characteristics of the reviewed studies (Continued)
• For Kid-Kindl: 11
(5 to 18)
• SDQ (proxy-parent): n = 48 • Psychological adjustment (SDQ): More
problems in all scales except conduct
problems
• For SDQ: 4
(1 to 18)
n according to age or degree
of mental retardation
Krivitzky
et al., 2009
(USA) [27]
UCD 92 Same 7.2 (0.4 to 16.75) Population
norms
• ABAS (proxy-parent): all ages • Adaptive functioning (ABAS): General
score was sign. lower for all IT-IEM groups
(neonatal onset, late onset, patients with/
without hyperammonemic history) in the
age group of 3-16 years
• Adaptive functioning (ABAS): General
score was sign. lower for the IT-IEM
patients with a hyperammonemic history,
not for the other subgroups, in the age
group of < 3 years.
• CBCL (proxy-parent): for
ages 3-16
• Psychological adjustment (CBCL): No
sign. group difference in internalising and
externalising problems
Mazariegos
et al., 2012
(USA) [20]
MSUD 31 Reviewed sample: Patients with
results for adaptive functioning
Orig. sample: Patients with
and without results for
adaptive functioning (N = 35)
9.9 (1.7 to 32.1)
(for N = 35)
Population
norms
• ABAS (self ) or Vineland (self )
(for this review: only
pre-transplantation assessment)
• Adaptive functioning (ABAS or
Vineland): Sign. lower score for adaptive
functioning
• Risk factor assessment: Sign positive
correlation between IQ and adaptive
functioning
• Risk factor assessment: No sign.
correlation between adaptive test scores
and age at diagnosis, number of
preceding metabolic crises, number of
hospitalizations, age at transplantation
Muelly et al.,
2013 (USA)
[24]
MSUD 26 Reviewed sample: IT-IEM
patients on diet, not
liver-transplanted
Orig. sample: IT-IEM patients
on diet and IT-IEM after liver
transplantation (N = 37)
• For MSUD diet
n = 26: n.a.,
Mdn = 19.5
(7 to 35)
Healthy control
group (mostly
siblings of
MSUD-patients)
• SCID (adult or childhood version)
for DSM-IV: depression,
anxiety, ADHD, global,
social, occupational and
psychological functioning (self )
• Psychological adjustment (Severity of
depression and Anxiety, BDI, BAI, BYI):
No sign. group difference
• Psychological adjustment (Current
and lifetime depression and anxiety,
SCID for DSM-IV): Sign. more lifetime
depression and anxiety
• For controls
n = 26: n.a.,
Mdn = 15.9
(6 to 35)
• BDI and BAI or sub-scores of
the BYI of emotional and
social impairment (self )
• Risk factor assessment: Patients who
remained asymptomatic throughout
newborn period vs. patients who were
encephalopathic at the time of diagnosis:
Second group has higher risk to later
suffer from anxiety (5x higher) and from
depression (10x higher)
• Risk factor assessment: Correlation of
mood disturbances with some
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Table 1 Main characteristics of the reviewed studies (Continued)
biochemical parameters. No strong
correlation of depression and anxiety with
indices of lifetime metabolic control
Packman
et al., 2007
(USA) [28]
MSUD 55 Same 11 (5 to 18) Population
norms
• PedsQL (self, proxy-parent) • HrQoL (PedsQL): Total HrQoL score and
domains are closer to cancer sample
norms than to healthy sample norms
• BASC (proxy-parent,
proxy-teacher)
• Psychological adjustment and
adaptive functioning (BASC): Mostly no
sign. group difference. Sign. more
problems in some areas, sign. lower scores
in adaptive skills (parent- and teacher-
rating)
• Self- vs. proxy-rating: HrQoL self-report
> proxy-report for physical, emotional,
social domain, no difference for school
function
• Self- vs. proxy-rating: Behavioural
adjustment proxy parent- vs. proxy
teacher-report: parent < teacher for
internalising problems (somatization,
anxiety)
Pohorecka
et al., 2012
(Poland)[29]
TYR I 8 Same 11 (6 to 15) Population
norms
• CBCL (proxy-parent) • Psychological adjustment (CBCL): Sign.
more problems in several scales
Simons
et al., 2006
(Belgium)
[21]
OTCD, GA III, MMA 11 Reviewed sample: only IT-IEM
Orig. sample: IT-IEM mixed
with other IEM (N = 53)
n.a. (0-2 to 16)
(for N = 53)
Population
norms
• CBCL, TRF, YSR (proxy-parent,
proxy-teacher, self if child >
11 years old)
• Psychological adjustment (CBCL): No
sign. group difference
• K-SADS for DSM-IV
diagnosis (self )
• Psychological adjustment (K-SADS for
DSM-IV): Psychiatric diagnoses in n = 2,
but scale was not applied to the whole
sample
*The N reported corresponds to the highest number of participants for which HrQoL/psychological outcome is reported.
**Results are based on the statistic analysis done for this review. A “significant” outcome means that the calculated 95% CI of the effect size does not include the value of zero and is thus significant on a level of
p <0.05 (continuous results) or that the χ2−test revealed a significant result on a level of p <0.05 or lower (dichotomous results). The statements refer to IT-IEM patients related to the respective group of comparison.
Abbreviations diseases: AMD (Amino Acid Metabolism Disorders), ASA (Arginosuccinic Aciduria), ASLD (Adenylosuccinate Lyase Deficiency), CMD (Carbohydrate Metabolism Disorders), GA I (Glutaric Aciduria type I),
GA III (Glutaric Aciduria type III), HHH Syndrom (Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome), IEM (Inborn Errors of Metabolism), IVA (Isovaleric Aciduria), IT-IEM (Intoxication-type Inbron Errors of
Metabolism), MMA (Methylmalonic Aciduria), MSUD (Maple Syrup Urine Disease), OTCD (Ornithintranscarbamylase Deficiency), PA (Propionic Aciduria), TYR I (Tyrosinemia type I), UCD (Urea Cycle Disorder).
Abbreviations assessment instruments: ABAS (Adaptive Behavior Assessment System), BAI (Beck Anxiety Inventory), BASC (Behavior Assessment System for Children), BDI (Beck Depression Inventory), BYI (Beck Youth
Inventory), CBCL (Child Behaviour Check List) with YSF (Youth-report form) and TRF (Teacher-report form), DSM-IV (Diagnostic and Statistical Manual of Mental Disorders IV), Kiddy-, Kid-, Kiddo-KINDL (Revised
questionnaire to assess health-related quality of life in children and adolescents), K-SADS (Schedule for Affective Disorders and Schizophrenia for School-Age Children), PedsQL (Pediatric Quality of Life Inventory),
SDQ (Strengths and Difficulties Questionnaire), SCID (Structured clinical interview for DSM-IV), Vineland (Vineland Adaptive Behavior Scale), WHOQOL-100 (World Health Organisation Quality of Life assessment).
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Table 2 Overview of assessment instruments in the reviewed studies
Assessment instrument General use Reference
ABAS Adaptive behavior
assessment system
Assessment of adaptive behaviour and skills necessary for
daily living, for individuals from birth to 89 years. Thirteen
scales are organised in three general areas: conceptual,
social, practical. Versions for self- and different proxy-
reports are available.
Harrison, PL, Oakland, T (2003). Adaptive Behavior
Assessment System - Second Edition. San Antonio, TX:
The Psychological Corporation.
BAI Beck anxiety inventory Assessment of severity of anxiety of individuals aged
from 17 to 80 years. Consists of 21 multiple choice
questions for self-report.
Beck, A, Steer, R (1993). Manual for the Beck Anxiety
Inventory. San Antonio, Texas, USA: The
Psychological Corporation Harchourt Brace &
Company; 1993.
BASC Behavior assessment
system for children
Assessment of behaviour and self-perception of children
aged from 2 years 6 months to 18 years. Teacher-,
parent- and self-report versions available.
Reynolds CR, Kamphaus RW: Behavior assessment
system for children. Circle Pines, MN: American
Guidance Service 1992.
BDI Beck depression
inventory
Assessment of severity of depression of individuals aged
from 13 to 80 years. Consists of 21 multiple choice
questions for self-report.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J:
An inventory for measuring depression.
Arch Gen Psychiatry 1961,
4:561–571.
BYI Beck youth inventory Consisting of five inventories (anger, anxiety, depression,
disruptive behaviour, self-concept) for children and
adolescents aged from 7 to 17 years. Each inventory
consists of 20 questions for self-report.
Beck, J, Beck, A, Jolly, J (2001). Beck Youth
Inventories of Emotional and Social Impairment. San
Antonio, Texas USA: The Psychological Corporation.
CBCL Child behaviour check
list
Ratings of behavioural, emotional and social functioning
of children and adolescents aged from 1 year 6 month to
18 years. Behaviours are categorized into internalising
problem scales (e.g. anxiety, somatic complaints) and
externalising problem scales (e.g. aggressive behaviour,
attention problems). The CBCL is for parent-report, a
teacher-report form (TRF) and a youth-report form (YRF)
are available.
Achenbach, TM, & Rescorla, LA (2000). Manual for
the ASEBA Preschool Forms & Profiles. Burlington, VT:
University of Vermont, Research Center for Children,
Youth, & Families.
KINDL Revised questionnaire
to assess health-
related quality of life
in children and
adolescents
Generic instrument to assess health-related quality of life
in children and adolescents aged from 3 to 17 years.
Version for three age groups are available (Kiddy-, Kid-,
Kiddo-KINDL), each in self- and proxy-rating. Dimensions:
psychological well-being, social relationships, physical
function, everyday life activities.
Ravens-Sieberer U, Bullinger M: Assessing
health-related quality of life in chronically ill
children with the German KINDL: first
psychometric and content analytical results.
Qual Life Res 1998, 7:399–407.
K-SADS Schedule for affective
disorders and
schizophrenia for
school-age children
Semi-structured interview to make DSM-IV (Diagnostic
and Statistical Manual of Mental Disorders IV)
diagnoses in children and adolescents from aged
from 6 to 16 years. Answers from parents and
children are both considered.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C,
Moreci P, Williamson D, Ryan N: Schedule for
Affective Disorders and Schizophrenia for
School-Age Children-Present and Lifetime
Version (K-SADS-PL): initial reliability and
validity data. J Am Acad Child Adolesc Psychiatry
1997, 36:980–988.
PedsQL Pediatric quality of
life inventory
Assessment of health-related quality of life in children
and adolescents aged from 2 to 18 years. Can be
used in healthy individuals (generic module) and in
those with health conditions (additional disease-
specific modules). Self- and proxy-report versions are
available. Consists of 23 items forming the generic
module. Disease-specific modules are available e.g.
for asthma, diabetes, cancer. Scales: Physical,
emotional, social and school functioning.
Varni JW, Seid M, Rode CA: The PedsQL:
measurement model for the pediatric quality of
life inventory. Med Care 1999, 37:126–139.
SCID Structured clinical
interview for DSM-IV
Semi-structured interview to make DSM-IV
(Diagnostic and Statistical Manual of Mental
Disorders IV) diagnoses in adults, version for
children is available.
First MB, Spitzer, RL, Gibbon, M, Williams, JBW:
Structured clinical interview for DSM-IV_TR Axis I
Disorders, Research Version, Non-Patient Edition.
New York, NY: Biometrics Research, New York
State Psychiatric Institute; 2002.
SDQ Strengths and
difficulties
questionnaire
Instrument to screen behavioural strengths and
difficulties in children and adolescents aged from
3–16 years. Parent- or teacher-report, available in
self-report for 11–16 year olds. 25 Items for 5 scales:
emotional symptoms, conduct problems, hyperactivity/
inattention, peer relationship problems, prosocial behaviour.
Goodman R: The Strengths and Difficulties
Questionnaire: a research note. J Child
Psychol Psychiatry 1997, 38:581–586.
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compared to population norms were described in one
paper [25].
Proxy-parent vs. proxy-teacher-report
According to one study, teachers reported more interna-
lising problems (somatisation, anxiety) than parents [28].
Risk factors
For psychological adjustment and adaptive functioning
parameters, several risk factors were investigated. The
risk for lifetime anxiety or lifetime depression disorders
was higher in patients who were encephalopathic at
diagnosis than patients who were non-symptomatic at
diagnosis [24]. Adaptive functioning correlated with IQ
according to another study, but no correlation was found
between adaptive functioning and age at diagnosis, num-
ber of preceding metabolic crises, or number of hospitali-
sations [20]. Finally, lower scores in adaptive functioning
were found among patients with neonatal onset than
among late-onset patients, but no difference was found in
the number of hyperammonemic events [27].
Discussion
HrQoL, psychological adjustment, and adaptive
functioning
The first aim of our systematic review was to explore the
current state of research on HrQoL, psychological adjust-
ment, and adaptive functioning in patients with IT-IEM.
We found 11 articles reporting HrQoL, psychological
adjustment, or adaptive functioning for this group of
patients. Results for HrQoL varied across studies from
lower HrQoL to similar and better scores for IT-IEM
patients compared to norms. Notably, proxy-ratings of
patients’ HrQoL were consistently similar or lower than
norms. Results for psychological adjustment and adaptive
functioning varied less and were mostly comparable to
norms or showed worse adjustment for IT-IEM patients.
Fewer problems were only reported once [25] – however,
this result has to be considered with care. The sample size
of this study was very small (n = 4) compared to the other
studies, and the authors themselves expressed some
doubts about the reliability of their results.
Impaired HrQoL, psychological adjustment, or adaptive
functioning can have different causes. Firstly, this may be
a result of the distress experienced in IT-IEM, such as fear
of metabolic crises or social problems associated with the
diet [9]. Secondly, neurological sequelae of IT-IEM can
lead directly to cognitive or psychological problems and
thus to worse psychological adjustment and adaptive func-
tioning in everyday life (e.g. psychotic or depressive symp-
toms through CNS damage) [5]. Thirdly, it is important to
consider the interaction between HrQoL and psycho-
logical adjustment, since the literature shows impaired
HrQoL in patients with mental disorders [7]. Therefore,
impaired HrQoL may be caused by mental health prob-
lems. In contrast, good HrQoL in IT-IEM patients may be
explained by the theory of response shift [30]. This would
account for the often-seen improvement of HrQoL in
chronically ill patients as a result of an accommodation
process which involves changing internal standards,
values and conceptualisation. According to Sprangers and
Schwartz [30], a response shift results from the interaction
of different variables: health status, mechanisms such as
coping, and antecedents such as personality or socio-
demographics.
Interestingly, HrQoL was more often reported to be im-
paired when rated by parents compared to self-ratings by
patients. In line with this, a comparison of self- and
proxy-ratings revealed better self-ratings in most domains
[28]. The fact that HrQoL of children with chronic health
conditions is rated lower by parents than by the children
themselves is well known from the literature [31]. Further-
more, there is a close relation between the parent’s rating
of a child’s HrQoL and the parent’s own HrQoL [32]:
Parents experiencing low HrQoL rate their child’s HrQoL
low as well. This might be especially relevant in parents of
children with IT-IEM, since these diseases demand inten-
sive care and may have a great impact on the lives of
caregivers [33]. Another explanation for the lower proxy-
ratings may be the ability of parents to anticipate the
future problems of the child. Young children in particular
may not be aware of these to the same extent.
Table 2 Overview of assessment instruments in the reviewed studies (Continued)
Vineland Vineland adaptive
behavior scale
Assessment of adaptive behaviour and skills necessary for
daily living from birth to 90 years. Scales refer to
functions necessary for daily living and are organised in
three main areas: Communication, daily living skills,
socialization. Self-, caregiver- and teacher-rating forms are
available.
Sparrow SS, Cicchetti, DV, Balla, DA: Vineland
Adaptive Behavior Scales. Circle Pines, MN: AGS
Publishing; 2005.
WHOQOL-
100
World health
organisation quality of
life assessment
Instrument to assess subjective quality of life in adults.
Self- and proxy-report version available. Dimensions:
physical, psychological, independence, social,
environment, religion/spirituality.
The WHOQOL Group: The World Health
Organization Quality of Life Assessment
(WHOQOL): development and general
psychometric properties. Soc Sci Med 1998,
46:1569–1585.
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Table 3 Continuous outcomes in the reviewed studies
Reference CI of d
N Instrument Subscale ES1: Cohen's d Lower Upper Sign.
Health-related quality of life: self-report
Compared to population norms
Cazzorla et al., 2012 [22] WHOQOL-100 General n.a. n.a. to n.a. n.a.
N = 15 Physical 0.62 0.10 to 1.13 *
Psychological 0.52 0.00 to 1.04 ns
Independence n.a. n.a. to n.a. n.a.
Social −0.13 −0.64 to 0.39 ns
Environmental −2.43 −2.97 to −1.89 *
Spiritual n.a. n.a. to n.a. n.a.
Medication n.a. n.a. to n.a. n.a.
Compared to PKU
General 0.03 −0.69 to 0.74 ns
Physical 0.16 −0.56 to 0.88 ns
Psychological 0.70 −0.04 to 1.44 ns
Independence −0.34 −1.06 to 0.38 ns
Social 0.14 −0.58 to 0.85 ns
Environmental 0.41 −0.31 to 1.14 ns
Spiritual 0.31 −0.41 to 1.04 ns
Medication 0.70 −0.04 to 1.44 ns
Compared to Morbus Fabry
General 1.15 0.35 to 1.95 *
Physical 1.49 0.65 to 2.33 *
Psychological 0.90 0.12 to 1.68 *
Independence 1.11 0.31 to 1.90 *
Social 0.70 −0.06 to 1.47 ns
Environmental 0.91 0.13 to 1.69 *
Spiritual 1.07 0.28 to 1.87 *
Medication −0.35 −1.10 to 0.40 ns
Compared to IEM with pharmacological
treatment
General 0.92 0.27 to 1.56 *
Physical 1.19 0.53 to 1.86 *
Psychological 0.94 0.30 to 1.59 *
Independence 0.74 0.11 to 1.38 *
Social 0.16 −0.46 to 0.78 ns
Environmental 0.75 0.12 to 1.39 *
Spiritual 0.90 0.25 to 1.54 *
Medication −0.26 −0.88 to 0.36 ns
Compared to population norms
Grünert et al., 2013 [26] KINDL Total −0.34 −0.81 to 0.12 ns
N = 18 Physical −0.28 −0.74 to 0.19 ns
Psychological −0.78 −1.25 to −0.32 *
Self-esteem 0.15 −0.32 to 0.63 ns
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Table 3 Continuous outcomes in the reviewed studies (Continued)
Family −0.38 −0.84 to 0.09 ns
Friends −0.68 −1.14 to −0.21 *
School 0.73 0.22 to 1.24 *
Illness n.a. n.a. to n.a. n.a.
Compared to healthy population norms
Packman et al., 2007 [28] PedsQL self-report Physical function −0.28 −0.69 to 0.13 ns
N = 55 Emotional function −0.55 −0.96 to −0.14 *
Social function −0.80 −1.22 to −0.39 *
School function −0.70 −1.12 to −0.29 *
Psychosocial −0.85 −1.27 to −0.44 *
Total −0.77 −1.19 to −0.36 *
Compared to cancer population norms
Physical function 0.42 0.00 to 0.84 ns
Emotional function −0.04 −0.46 to 0.38 ns
Social function −0.24 −0.66 to 0.19 ns
School function −0.24 −0.67 to 0.18 ns
Psychosocial −0.23 −0.65 to 0.19 ns
Total −0.02 −0.44 to 0.40 ns
Health-related quality of life: proxy-report
Compared to CMD
Eminoglu et al., 2013 [23] QOL scale for metabolic disease Impact of IEM −0.18 −1.02 to 0.67 ns
N = 14 Attention −0.42 −1.15 to 0.31 ns
Self-esteem about IEM 0.03 −0.70 to 0.76 ns
Physical function −0.65 −1.38 to 0.08 ns
Labeling −0.57 −1.41 to 0.27 ns
Social support 0.17 −0.69 to 1.03 ns
School status −0.93 −1.77 to −0.09 *
Health perception −1.69 −2.64 to −0.74 *
KINDL Emotional wellbeing −0.44 −1.07 to 0.19 ns
Compared to AMD
QOL scale for metabolic disease Impact of IEM −0.24 −1.18 to 0.69 ns
Attention −0.64 −1.43 to 0.16 ns
Self-esteem about IEM −0.45 −1.26 to 0.36 ns
Physical function −1.14 −1.96 to −0.33 *
Labeling −0.15 −1.02 to 0.71 ns
Social support −0.55 −1.47 to 0.38 ns
School status −1.41 −2.41 to −0.40 *
Health perception −1.67 −2.70 to −0.64 *
KINDL Emotional wellbeing −0.20 −0.88 to 0.48 ns
Compared to population norms
QOL scale for metabolic disease n.a. n.a. to n.a. n.a.
KINDL n.a. n.a. to n.a. n.a.
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Table 3 Continuous outcomes in the reviewed studies (Continued)
Compared to healthy population norms
Packman et al., 2007 [28] PedsQL proxy-report Physical function −1.14 −1.54 to −0.74 *
N = 55 Emotional function −1.19 −1.59 to −0.80 *
Social function −1.48 −1.88 to −1.08 *
School function −1.46 −1.86 to −1.06 *
Psychosocial −1.66 −2.06 to −1.26 *
Total −1.65 −2.05 to −1.25 *
Compared to cancer population norms
Physical function −0.06 −0.46 to 0.34 ns
Emotional function −0.23 −0.63 to 0.17 ns
Social function −0.65 −1.05 to −0.25 *
School function −0.39 −0.80 to 0.01 ns
Psychosocial −0.54 −0.94 to −0.14 *
Total −0.40 −0.80 to 0.00 ns
Psychological adjustment and adaptive functioning:
self-report
Compared to population norms
Muelly et al., 2013 [24] BDI/BYI BDI score adults 0.54 −0.02 to 1.11 ns
N = 26 BYI T-score −0.44 −1.01 to 0.12 ns
Combined z-score 0.19 −0.36 to 0.75 ns
BAI/BYI BAI score adults 0.38 −0.18 to 0.94 ns
BYI T-score −0.28 −0.83 to 0.28 ns
Combined z-score 0.13 −0.43 to 0.68 ns
Compared to population norms
Mazariegos et al., 2012 [20] Vineland or ABAS Total −1.09 −1.46 to −0.72 *
N = 31
Psychological adjustment and adaptive functioning:
proxy-report
Compared to population norms
Beauchamp et al., 2009 [25] CBCL Internalising problems −0.32 −1.31 to 0.66 ns
N = 4 Externalising problems −0.76 −1.74 to 0.23 ns
Total −1.32 −2.31 to −0.34 *
ABAS General score −0.23 −1.21 to 0.75 ns
Conceptual −0.65 −1.63 to 0.34 ns
Social 0.84 −0.14 to 1.82 ns
Practical −0.50 −1.48 to 0.48 ns
Neonatal onset vs. population
norms
Krivitzky et al., 2009 [27] ABAS, age <3 y General score −0.35 −0.83 to 0.13 ns
N = 92 ABAS, age 3-16y General score −2.09 −2.64 to −1.53 *
Late onset vs. population norms
ABAS, age <3 y General score −0.67 −1.42 to 0.07 ns
ABAS, age 3-16y General score −0.76 −1.04 to −0.47 *
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Table 3 Continuous outcomes in the reviewed studies (Continued)
Hyp.amm. events > 0 vs. population
norms
ABAS, age <3 y General score −0.37 −0.88 to −0.37 *
ABAS, age 3-16y General score −1.00 −1.33 to −0.99 *
Hyp.amm. events =0 vs. population
norms
ABAS, age <3 y General score −0.55 −1.20 to 0.11 ns
ABAS, age 3-16y General score −0.96 −1.36 to −0.56 *
Compared to population norms
Packman et al., 2007 [28] BASC parent-report Hyperactivity 0.26 −0.03 to 0.55 ns
N = 55 Aggression 0.24 −0.04 to 0.53 ns
Conduct problems 0.03 −0.25 to 0.32 ns
Anxiety 0.05 −0.24 to 0.34 ns
Depression 0.08 −0.21 to 0.36 ns
Somatization 0.21 −0.08 to 0.50 ns
Atypicality 0.30 0.01 to 0.59 *
Withdrawal 0.04 −0.24 to 0.33 ns
Attention problems 0.68 0.39 to 0.97 *
Externalising problems 0.21 −0.08 to 0.50 ns
Internalising problems 0.14 −0.15 to 0.43 ns
Behavioral sympt. index 0.37 0.08 to 0.66 *
Adaptive skills −0.59 −0.88 to −0.30 *
Compared to population norms
BASC teacher-report Hyperactivity 0.41 0.07 to 0.76 *
Aggression 0.28 −0.07 to 0.62 ns
Conduct problems −0.18 −0.52 to 0.16 ns
Anxiety 0.55 0.20 to 0.89 *
Depression 0.11 −0.23 to 0.45 ns
Somatization 0.66 0.32 to 1.01 *
Attention problems 0.75 0.41 to 1.10 *
Learning problems 0.74 0.39 to 1.08 *
Atypicality 0.68 0.34 to 1.03 *
Withdrawal 0.19 −0.15 to 0.53 ns
Externalising problems 0.23 −0.12 to 0.57 ns
Internalising problems 0.56 0.21 to 0.90 *
School problems 0.76 0.42 to 1.11 *
Behavioral sympt. index 0.62 0.28 to 0.97 *
Adaptive Skills −0.36 −0.71 to −0.02 *
Compared to population norms
Pohorecka et al., 2012 [29] CBCL Internalising problems 1.14 0.44 to 1.84 *
N = 8 Externalising problems 0.77 0.08 to 1.47 *
Withdrawn 1.30 0.60 to 2.01 *
Somatic complaints 1.19 0.49 to 1.90 *
Anxious depressed 0.62 −0.08 to 1.32 ns
Social problems 1.52 0.82 to 2.23 *
Thought problems 0.89 0.19 to 1.59 *
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A major reason for the inconsistent findings may be
attributed to methodological issues. Most of the HrQoL
instruments were not specifically tailored to patients
with IT-IEM. One study used an invalidated disease-
specific instrument [23]. In addition, the HrQoL of IT-IEM
patients was compared to different groups: population
norms or other metabolic diseases. Sample sizes were often
small, a state of affairs that is often found in paediatric
research and especially in research in the field of rare
diseases. Statistically, such small sample sizes make it more
difficult to detect group differences. In addition, one study
had a clear selection bias by only including patients who
were cognitively able to answer questionnaires [26].
Another significant limitation is the choice of informants;
most studies used proxy-reports which do not fully reflect
self-reports of the patients. It is clear from the literature
that these two kinds of reports are not interchangeable [32].
Risk factors for HrQoL, psychological adjustment, and
adaptive functioning
The second aim of this review was to detect risk factors
for HrQoL, psychological adjustment, and adaptive
functioning for IT-IEM patients. Only a few risk factors
for psychological adjustment and adaptive functioning
have been investigated so far, and none have been ex-
amined for HrQoL. The risk factors examined were
mainly medical [20,24,27]. With regard to cognitive pa-
rameters, IQ was investigated in one study [20]. Two
studies revealed that metabolic events in the neonatal
period were associated with psychosocial adjustment:
patients diagnosed as encephalopathic newborns had a
higher risk of suffering from anxiety or depression dur-
ing their lifetime than patients who were metabolically
stable during the newborn period [24]. Adaptive func-
tioning scores were lower for neonatal-onset than for
late-onset patients [27]. Similar results have been found
before and may be explained by the fact that crises have
a negative impact on the developing brain, especially in
highly vulnerable newborns [24,34].
Strengths and limitations of this review
This systematic review was conducted in accordance to
the PRISMA guidelines (Preferred Reporting Items for
Systematic Reviews and Meta-Analysis) [35]. In order to
find as many eligible studies as possible, we applied several
search strategies: we searched different databases and did
not restrict the search to English articles. Additionally, we
tried to find additional and/or unpublished studies by ref-
erence screening and contacting experts in the field. Study
selection and data extraction were conducted independ-
ently by two reviewers, thereby diminishing the risk of
bias. The main weakness of our review is the inability to
pool results from the different studies. The different study
designs and assessment methods did not permit such
meta-analytic calculations. Nevertheless, better compar-
ability of the results was attained by indicating effect sizes
and their CI. Another limitation of this systematic review
can be found in our comparison of studies with very dif-
ferent sample sizes (ranging from N = 4 to N = 92), the
reason why the calculated effect sizes have to be inter-
preted carefully. Because the incidence rates of rare dis-
eases are small and because there is only a very limited
number of studies that could be included in our review,
we decided not to exclude studies with small sample sizes
(inclusion criterion N >1). To account for this limitation,
we considered sample sizes in the calculation of effect
sizes by correcting mechanisms. The different sizes were
also taken into account by computing CIs of effect sizes.
Suggestions for future research
Based on the findings of this review, several implications
can be drawn. Firstly, HrQoL should be considered as an
essential outcome parameter in future clinical trials. Up to
now, treatment evaluations of patients with IT-IEM have
predominantly focused on medical outcomes. However,
because survival rates have increased considerably, im-
provement of HrQoL for patients with IT-IEM must be
an additional major goal of new treatments.
Table 3 Continuous outcomes in the reviewed studies (Continued)
Attention problems 1.15 0.45 to 1.86 *
Rule breaking behaviour 1.07 0.37 to 1.77 *
Aggressive behaviour 0.86 0.16 to 1.56 *
Compared to population norms
Simons et al., 2006 [21] CBCL Internalising problems 0.79 −0.02 to 1.59 ns
N = 11 Externalising problems 0.36 −0.44 to 1.17 ns
Total 0.64 −0.17 to 1.44 ns
1A positive value means that the IT-IEM group scored higher than the control group. A negative value means that the IT-IEM group scored lower than the control
group. Higher values are favourable in all scales except for the BASC [28] where high scores mean more problems (exception: BASC subscale adaptive skills).
Abbreviations: ABAS (Adaptive Behavior Assessment System), BAI (Beck Anxiety Inventory), BASC (Behavior Assessment System for Children), BDI (Beck
Depression Inventory), BYI (Beck Youth Inventory), CBCL (Child Behaviour Check List), KINDL (Revised questionnaire to assess health-related quality of life in
children and adolescents), PedsQL (Pediatric Quality of Life Inventory), Vineland (Vineland Adaptive Behavior Scale), WHOQOL-100 (World Health Organization
Quality of Life assessment).
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Table 4 Dichotomous outcomes in the reviewed studies
Reference
N
Instrument Subscale n IT-IEM n
control
Results Test of between group
significance
Cramer's V
Psychological adjustment, self-report
% present IT-IEM/% present control Compared to healthy control
group
Muelly et al., 2013
[24]
SCID, DSM-IV Depression current 26 26 29/4 χ2 = 22.68; df = 1;
p (2-tail) = 0.000 (***)
0.34
N = 26 Depression lifetime 26 26 42/19 χ2 = 12.48; df = 1;
p (2-tail) = 0.000 (***)
0.25
Anxiety current 26 26 42/15 χ2 = 17.89; df = 1;
p (2-tail) = 0.000 (***)
0.30
Anxiety lifetime 26 26 58/31 χ2 = 14.96; df = 1;
p (2-tail) = 0.000 (***)
0.27
Psychological adjustment, proxy-report
n IT-IEM in different categories (n control n.a.) No group of comparison
Gramer et al., 2013
[19]
Perceived burden for the
child
34 none No (n = 5), little (n = 17), middle (n = 5), heavy (n = 4), very
heavy (n = 3)
n.a. n.a.
N = 34
Social behaviour 34 none Lower than norm (n = 3), same as norm (n = 28), higher than
norm (n = 3)
n.a. n.a.
% normal/at risk/clinically sign. IT-IEM Compared to population
norms
(% normal/at risk/clinically sign. control)
Grünert et al., 2013
[26]
SDQ Emotional symptoms 48 930 62/13/25 (84/7/9) χ2 = 12.64; df = 2;
p (2-tail) = 0.002 (**)
0.25
N = 48 Conduct problems 46 930 54/26/20 (69/16/15) χ2 = 4.93; df = 2;
p (2-tail) = 0.085 (ns)
0.15
Hyperactivity/Inattention 47 930 62/28/10 (86/6/8) χ2 = 18.35; df = 2;
p (2-tail) = 0.000 (***)
0.30
Peer relationship problem 46 930 39/20/41 (78/11/12) χ2 = 32.92; df = 2;
p (2-tail) = 0.000 (***)
0.40
Prosocial behaviour 47 930 57/9/34 (89/7/4) χ2 = 30.95; df = 2;
p (2-tail) = 0.000 (***)
0.39
Influence on child's life 48 930 60/11/29 (n.a.) n.a. n.a.
Total 46 930 52/20/28 (85/8/7) χ2 = 25.69; df = 2;
p (2-tail) = 0.000 (***)
0.36
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Table 4 Dichotomous outcomes in the reviewed studies (Continued)
% normal/at risk/clinically sign. IT-IEM Compared to population
norms
(% normal/at risk/clinically sign. control)
Krivitzky et al., 2009
[27]
CBCL Internalising problems 68 576 79/17/4 (83/7/11) χ2 = 5.87; df = 2;
p (2-tail) = 0.053 (ns)
0.17
N = 92 Externalising problems 68 576 80/16/4 (83/7/11) χ2 = 5.26; df = 2;
p (2-tail) = 0.072 (ns)
0.16
Abbreviations: CBCL (Child Behaviour Check List), DSM-IV (Diagnostic and Statistical Manual of Mental Disorders IV), SCID (Structured Clinical Interview for DSM-IV), SDQ (Strengths and Difficulties Questionnaire).
Zeltner
et
al.O
rphanet
Journalof
Rare
D
iseases
2014,9:159
Page
16
of
18
http://w
w
w
.ojrd.com
/content/9/1/159
Secondly, it is important to increase the methodological
quality of psychosocial research among IT-IEM patients.
Multicentre studies are necessary both to avoid conveni-
ence sampling with a high risk for biased data and to
increase sample sizes. International patient registries (e.g.
E-IMD, www.e-imd.com) can help to achieve this goal
and to aggregate knowledge. This review has shown that a
variety of assessment instruments is currently in use, thus
complicating the pooling of results. Most of the studies
used generic, non-disease-specific instruments. Only one
of the reviewed studies used a disease-specific scale [23];
however, this was not validated. Generic instruments have
the advantage that results can usually be compared to a
healthy population or a population with another disease
[6]. However, they do not assess the specific problems of
medical conditions. In contrast, disease-specific HrQoL
scales are related to the distinct effects of a particular
disease [5]. They are more sensitive for special topics that
are of interest and more meaningful for specific groups of
patients. The use of disease-specific HrQoL assessment
measures in clinical trials has been shown to be valuable
in other severe medical conditions [5]. To date, no vali-
dated, disease-specific measure is available for patients
with IT-IEM. Furthermore, from a methodological view-
point, it is desirable to consider different informants; be-
cause proxy-reports have several limitations, the patients’
well-being should also be assessed using self-ratings.
Thirdly, knowledge of risk factors influencing HrQoL,
psychological adjustment, and adaptive functioning is of
great importance. Very few studies have addressed this
topic at all, and where they did, research was restricted
to medical or biochemical parameters or IQ. Medical pa-
rameters are weak predictors for HrQoL in most chronic
diseases [5]. In contrast, a systematic review exploring
HrQoL in rare genetic conditions has emphasised that
parameters explaining how patients coped with their dis-
ease were good predictors of HrQoL [5]. As an example,
the authors mentioned scales such as “acceptance of
disability” or “sense of coherence”, which were positive
predictors for QoL, while feeling hopeless or having a
fatalistic view correlated with lower QoL [5]. Other pre-
dictors for HrQoL in chronic disease described in the
literature include concepts such as locus of control,
attachment, or well-being of the parents [8,36,37]. In
IT-IEM patients, such individual and familial psycho-
social risk factors have not yet been studied. Current
research is, unfortunately, still focused on a fully
biomedical model, instead of including the promising
psychosocial perspective [5].
Clinical implications
The small number of studies, partially inconsistent results,
and the few risk factors addressed make it difficult to draw
implications for clinical practice. Since HrQoL, psycho-
logical adjustment, and adaptive functioning seem to be
impaired in some patients, we suggest offering psycho-
logical support for patients and their families to help them
cope more effectively with the disease. Knowing more
about risk factors would allow the development of tar-
geted interventions for certain groups of patients. Overall,
we consider it important to support patients and their
families with a comprehensive care model, including
psychological and social interventions to complement the
medical ones [12,21].
Conclusion
Research data on psychosocial factors in IT-IEM patients
are generally sparse. However, the growing interest in the
topic is underlined by the fact that seven of the 11 articles
reviewed were published in 2012 or 2013. Further research
and improved methodological quality of studies are re-
quired. Multicentre studies and the use of a standardised,
disease-specific assessment tools are needed to establish
HrQoL as an important additional outcome parameter in
patient-centred research and clinical trials.
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